11c-metomidate
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started May 21, 2018 (NCT03990701)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 11-carbon
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06100367 | Phase 2/Phase 3 (Phase 3) | Dec 30, 2019 | Changi General Hospital, Khoo Teck Puat Hospital, Nanyang Technological University, National University of Singapore, Ng Teng Fong General Hospital, Sengkang General Hospital, Singapore General Hospital |
| NCT03990701 | Early Phase 1 (Phase 1) | May 21, 2018 | Changi General Hospital, Khoo Teck Puat Hospital, Nanyang Technological University, National University of Singapore, Ng Teng Fong General Hospital, Singapore General Hospital |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Changi General Hospital | Academic/Hospital | 2 | 2 | 2 | 2018 |
| Khoo Teck Puat Hospital | Academic/Hospital | 2 | 0 | 2 | 2018 |
| Nanyang Technological University | Academic/Hospital | 2 | 0 | 2 | 2018 |
| National University of Singapore | Academic/Hospital | 2 | 0 | 2 | 2018 |
| Ng Teng Fong General Hospital | Academic/Hospital | 2 | 0 | 2 | 2018 |
| Singapore General Hospital | Academic/Hospital | 2 | 0 | 2 | 2018 |
| Sengkang General Hospital | Academic/Hospital | 1 | 0 | 1 | 2019 |
7 organizations
Page 1 / 1